Content
05/02/2024
Redwood City, CA USA
Karius
completed $100 million Series C Round funding. Investors include
Khosla Ventures (lead), Gilde Healthcare (lead), 5AM Ventures (lead), General Catalyst, Innovation Endeavors, Seventure Partners, Softbank Vision Fund.
About
Karius sees a world where infectious disease is no longer a major threat to human health. The Karius Test uses genomics and AI to map a patient’s microbial landscape from a single blood sample to enable clinicians to make rapid treatment decisions.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
